Pharmacokinetics and Effect of Ticlopidine on Platelet Aggregation in Subjects with Normal and Impaired Renal Function
- 1 February 1997
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 37 (2) , 108-115
- https://doi.org/10.1002/j.1552-4604.1997.tb04768.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antithrombotic therapies for stroke preventionCurrent Opinion in Neurology, 1994
- Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.Stroke, 1993
- A Critical Appraisal of Ticlopidine, a New Antiplatelet AgentArchives of internal medicine (1960), 1992
- Prophylactic Antiplatelet Therapy in Peripheral Arterial DiseaseDrugs, 1991
- Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre StudyJournal of Internal Medicine, 1990
- Ticlopidine prevents renal disease progression in rats with reduced renal massKidney International, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989
- TiclopidineDrugs, 1987
- Thromboprophylactic Effect of Ticlopidine in Arteriovenous Fistulas for HaemodialysisScandinavian Journal of Urology and Nephrology, 1985